Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation

J Dong, XD Cheng, WD Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates various biological processes, including proliferation, metastasis, angiogenesis …

Structural modification aimed for improving solubility of lead compounds in early phase drug discovery

B Das, ATK Baidya, AT Mathew, AK Yadav… - Bioorganic & Medicinal …, 2022 - Elsevier
Many lead compounds fail to reach clinical trials despite being potent because of low
bioavailability attributed to their insufficient solubility making solubility a primary and crucial …

Expedition of sulfur‐containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update

K Laxmikeshav, P Kumari… - Medicinal Research …, 2022 - Wiley Online Library
This review article proposes a comprehensive report of the design strategies engaged in the
development of various sulfur‐bearing cytotoxic agents. The outcomes of various studies …

[HTML][HTML] Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance

X Liu, J Xu, J Zhou, Q Shen - Genes & diseases, 2021 - Elsevier
Cancer is one of the diseases with high morbidity and mortality on a global scale.
Chemotherapy remains the primary treatment option for most cancer patients, including …

Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery

SR Alizadeh, SM Hashemi - Medicinal Chemistry Research, 2021 - Springer
Currently, the development of anticancer drug resistance is significantly restricted the clinical
efficacy of the most commonly prescribed anticancer drug. Malignant disease is widely …

Discovery and development of natural product oridonin-inspired anticancer agents

Y Ding, C Ding, N Ye, Z Liu, EA Wold, H Chen… - European journal of …, 2016 - Elsevier
Natural products have historically been, and continue to be, an invaluable source for the
discovery of various therapeutic agents. Oridonin, a natural diterpenoid widely applied in …

Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection

J Xu, EA Wold, Y Ding, Q Shen, J Zhou - Molecules, 2018 - mdpi.com
Oridonin, a diterpenoid natural product commonly used in East Asian herbal medicine, is
garnering increased attention in the biomedical community due to its extensive biological …

Insights into drug discovery from natural products through structural modification

J Chen, W Li, H Yao, J Xu - Fitoterapia, 2015 - Elsevier
Natural products (NPs) have played a key role in drug discovery and are still a prolific
source of novel lead compounds or pharmacophores for medicinal chemistry …

Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents

H Chen, Y Gao, A Wang, X Zhou, Y Zheng… - European journal of …, 2015 - Elsevier
Currently, there is a renewed interest in common dietaries and plant-based traditional
medicines for the prevention and treatment of cancer. In the search for potential anticancer …

Discovery, X-ray crystallography, and anti-inflammatory activity of bromodomain-containing protein 4 (BRD4) BD1 inhibitors targeting a distinct new binding site

Z Liu, Y Li, H Chen, HT Lai, P Wang… - Journal of medicinal …, 2022 - ACS Publications
Bromodomain-containing protein 4 (BRD4) is an emerging epigenetic drug target for
intractable inflammatory disorders. The lack of highly selective inhibitors among BRD4 …